Sherry Ho

Sherry Ho has extensive work experience in the field of laboratory medicine and research. Sherry has served as a Laboratory Director at INEX Innovate since 2018. Prior to this, they worked at National University Hospital as a Postdoctoral Fellow from 2011 to 2018, where they led assay development and validation for various medical areas, including oncology, prenatal testing, and rare diseases. Sherry also presented findings to clinicians and scientists and was involved in grant writing and management. Before that, they worked as a Research Fellow at the National University of Singapore from 2009 to 2011, mentoring PhD students and supporting laboratory projects. Sherry also gained experience as a Research Assistant at the same institution from 2007 to 2008, focusing on molecular diagnosis and prenatal testing techniques. Sherry started their career as a Medical Technologist at Parkway Pantai Limited, where they were responsible for various cytogenetic laboratory tasks.

Sherry Ho holds a Doctor of Philosophy (PhD) degree in Molecular Genetics, which they obtained from the National University of Singapore. Sherry completed this degree from 2003 to 2008. Prior to their PhD, they earned a Bachelor of Science (BSc) in Microbiology, General from the National University of Singapore, which they obtained from 1996 to 1999. In addition to their degrees, Sherry Ho has obtained certifications as a CAP Inspector in Cytogenetics from the College of American Pathologists (CAP) in April 2020, and as a CAP Inspector in Molecular Pathology including NGS from the same institution in December 2017. There is no further information available about Sherry Ho's education history beyond what is provided.